Yahoo Finance

IsoRay's Cesium-131 Cancer Treatment Products and Methods to Be Featured in Oral Presentations by Industry Leaders During the American Society for Radiation Oncology Convention ...

RICHLAND, WA--(Marketwired - Sep 9, 2014) - IsoRay Inc. (NYSE MKT: ISR) (www.isoray.com), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today ...

CesiumAstro CEO on Satellite Innovation, AI and Space Connectivity

In this Space & Defense Market Update presented by Arkaea Media Group and the New York Stock Exchange, CesiumAstro CEO Shey ...
Yahoo Finance

IsoRay's Proprietary Cesium-131 Product Line Will Be on Display at the American Society for Radiation Oncology (ASTRO) Convention

RICHLAND, WA--(Marketwired - October 14, 2015) - IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced ...
Nasdaq

Isoray’s Cesium-131 Spotlighted in Multiple Presentations at ASTRO

RICHLAND, Wash., Nov. 24, 2020 (GLOBE NEWSWIRE) -- The importance of Isoray, Inc.’s (NYSE American: ISR) Cesium-131 in treating prostate and brain cancers was underscored in multiple presentations at ...
Nasdaq

Perspective Therapeutics’ Cesium-131 Featured at the American Society for Radiation Oncology’s Annual Conference

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a precision oncology company developing alpha-particle therapies and ...